Dr. Liu was trained in organic and medicinal chemistry and has experience in various R&D roles during his fifteen years in pharmaceutical and biotechnology industries before extending his expertise to pharmaceutical Quality/CMC (Chemistry, Manufacturing, and Controls). His nine years’ regulatory affairs experience include supporting CMC development of new drugs at pre-IND and IND stages for regulatory submissions, and providing project management and technical oversight of contract manufacturing organizations (CMOs). He previously worked in industry with Syva, Dade Behring, Microgenics, and Geron, where he has played leadership roles in various healthcare product development and commercialization. He has developed synthesis of various classes of organic compounds across multiple therapeutic areas such as anticancer drugs, antiretroviral drugs, antibacterial drugs, immunosuppressant drugs, antiepileptic drugs and psychoactive drugs. Dr. Liu holds eight US patents. One of his scientific publications was highlighted in Science Concentration of the Chemical & Engineering News. His team at Dade Behring was recognized as the Center of Excellence in Organic Chemistry within the corporation. Dr. Liu obtained his Ph.D. in organic chemistry (with Distinction) from Boston College. He received postdoctoral fellowships from Princeton University and Stanford University. He is Regulatory Affairs Certified (RAC).

 Drug discovery and development, organic and medicinal chemistry